Athyrium Capital Management LP

company

About

Athyrium Capital Management is a specialized asset management company focusing on investment opportunities in the global healthcare sector.

  • 11 - 50

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
PE

**Note: CrunchBase does not maintain a complete list of the investments made by the Athyrium funds. Please see our website at www.athyrium.com for a complete list of these investments.**

Athyrium Capital Management, LP (“Athyrium”) is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector.

Athyrium is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940.

The Athyrium team has substantial investment experience in the healthcare sector across a wide range of asset classes including public equity, private equity, fixed income, royalties, and other structured securities.

Athyrium invests across all healthcare verticals including biopharma, medical devices and products, and healthcare services. The team partners with management teams to implement creative financing solutions to companies’ capital needs.

Athyrium advises funds with over $1.7 billion of committed capital. We value our investors and are thankful for the trust they have placed in us. Our investors consist of public and corporate pension funds, charitable endowments, insurance companies, funds-of-funds, family offices, university endowments, and sovereign wealth funds.

Investments

Number of Investments
Number of Lead Investments
2
1
Athyrium Capital Management LP has made 2 investments. Their most recent investment was on Oct 3, 2018, when Kala Pharmaceuticals raised $110M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Equity $110M Biotechnology Yes
Jun 7, 2018 Sound Physicians
Private Equity(PE) $2.15B Emergency Medicine